{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["anti-oxidants", "chronic liver disease", "hepatitis C", "liver fibrosis", "ozone/oxygen gas mixture"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38190482", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "22"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "22"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "10"}], "ELocationID": ["10.1515/jcim-2023-0239"], "Journal": {"ISSN": "1553-3840", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "01"}}, "Title": "Journal of complementary & integrative medicine", "ISOAbbreviation": "J Complement Integr Med"}, "ArticleTitle": "Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients.", "Pagination": {"StartPage": "131", "EndPage": "138", "MedlinePgn": "131-138"}, "Abstract": {"AbstractText": ["We examine how well ozone/oxygen gas therapy treats chronic hepatitis C patients with varying degrees of liver fibrosis. Also to study the effect of giving multiple anti-oxidants with the ozone/oxygen gas mixture, to see if this addition would have any additive or synergistic effect.", "Two hundred and twenty three patients with chronic hepatitis C. Liver biopsies were carried out at after 12\u00a0weeks of administering an ozone/oxygen gas mixture.", "The mean stage of fibrosis decreased from 1.98 to 1.41 and the mean grade of inflammation decreased from 10.08 to 7.94, both with a p value less than 0.001. After 12\u00a0weeks of treatment, mean PCR values increased. No single significant complication was recorded in a total of >9,000 settings of ozone therapy.", "Ozone oxygen gas mixture is safe and effective in treatment of hepatic fibrosis due to chronic viral hepatitis C."], "CopyrightInformation": "\u00a9 2023 Walter de Gruyter GmbH, Berlin/Boston."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Hepatology & Gastroenterology, Theodor Bilharz Research Institute, Giza, Egypt."}], "LastName": "Sadek", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Pathology, Theodor Bilharz Research Institute, Giza, Egypt."}], "LastName": "Abd El Hady", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Pathology, Theodor Bilharz Research Institute, Giza, Egypt."}], "LastName": "Olfat", "ForeName": "Hammam", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt."}], "LastName": "Abd El Hady", "ForeName": "Afaf A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Public Health, Theodor Bilharz Research Institute, Giza, Egypt."}], "LastName": "Wafy", "ForeName": "Wafaa", "Initials": "W"}, {"Identifier": ["0000-0002-5853-0050"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Anthropology, Medical Researches and Clinical Studies Institute, National Research Centre, Cairo, Egypt."}], "LastName": "Zaki", "ForeName": "Moushira", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry, Medical Researches and Clinical Studies Institute, National Research Centre, Cairo, Egypt."}], "LastName": "Youness", "ForeName": "Eman R", "Initials": "ER"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Complement Integr Med", "NlmUniqueID": "101313855", "ISSNLinking": "1553-3840"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Hepatitis C, Chronic"}, {"QualifierName": [], "DescriptorName": "Liver"}, {"QualifierName": ["pathology"], "DescriptorName": "Hepatitis C"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxygen"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jamison, DT, Summers, LH, Alleyne, G, Arrow, KJ, Berkley, S, Binagwaho, A, et al.. Global health 2035: a world converging within a generation. Lancet 2013;382:1898\u2013955."}, {"Citation": "Organization WH . Global health estimates . Geneva: World Heal. Organ.; 2012."}, {"Citation": "Dolnikov, S, Adam, R, Cherqui, D, Allard, MA. Liver transplantation in elderly patients: what do we know at the beginning of 2020? Surg Today 2020;50:533\u20139."}, {"Citation": "Kim, AY, Chung, RT. Coinfection with HIV-1 and HCV\u00a0\u2013 a one-two punch. Gastroenterology 2009;137:795\u2013814."}, {"Citation": "Jani, P, Patel, G, Yadav, P, Sant, L, Jain, H. Ozone therapy: the alternative medicine of future. Indian J Phys Med Rehabil 2012;2:196\u2013203."}, {"Citation": "Janhom, N, Whangchai, K. Ozone fumigation promotes antioxidant activities to retard chlorophyll degradation and cell death in \u2018Jinda\u2019 chili during storage. Postharvest Biol Technol 2023;202:112375."}, {"Citation": "Barnes, PJ, Karin, M. Nuclear factor-\u03baB\u00a0\u2013 a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066\u201371."}, {"Citation": "Serra, MEG, Baeza-Noci, J, Abdala, CVM, Luvisotto, MM, Bertol, CD, Anzolin, AP. Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map. Med Gas Res 2023;13:172."}, {"Citation": "Halfon, P, Khiri, H, Gerolami, V, Bourliere, M, Feryn, JM, Reynier, P, et al.. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996;25:307\u201311."}, {"Citation": "Germer, JJ, Harmsen, WS, Mandrekar, JN, Mitchell, PS, Yao, JDC. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument. J Clin Microbiol 2005;43:293\u20138."}, {"Citation": "Ishak, K, Baptista, A, Bianchi, L, Callea, F, De Groote, J, Gudat, F, et al.. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696\u20139."}, {"Citation": "Asrani, SK, Devarbhavi, H, Eaton, J, Kamath, PS. Burden of liver diseases in the world. J Hepatol 2019;70:151\u201371."}, {"Citation": "Bach, N, Thung, SN, Schaffner, F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15:572\u20137."}, {"Citation": "Bility, MT, Cheng, L, Zhang, Z, Luan, Y, Li, F, Chi, L, et al.. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 2014;10:e1004032."}, {"Citation": "Xing, Y, Zhong, W, Peng, D, Han, Z, Zeng, H, Wang, Y, et al.. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: a multicenter, randomized clinical trial. Pharmacol Res 2023;190:106737."}, {"Citation": "Chen, Y, Li, J, Zeng, M, Lu, L, Qu, D, Mao, Y, et al.. The inhibitory effect of oxymatrine on hepatitis C virus in\u00a0vitro. Chinese J Hepatol 2001;9:12\u20134."}, {"Citation": "Yang, W, Zeng, M, Fan, Z, Mao, Y, Song, Y, Jia, Y, et al.. Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis. Chinese J Hepatol 2002;10:193\u20136."}, {"Citation": "Fallowfield, JA, Iredale, JP. Reversal of liver fibrosis and cirrhosis\u00a0\u2013 an emerging reality. Scott Med J 2004;49:3\u20136."}, {"Citation": "Kim, K-Y, Choi, I, Kim, S-S. Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol Cells. 2000;10:289\u2013300."}, {"Citation": "Coutinho, EM, Barros, AF, Barbosa, AJr, Oliveira, SA, Silva, LM, Ara\u00fajo, RE, et al.. Host nutritional status as a contributory factor to the remodeling of schistosomal hepatic fibrosis. Mem Inst Oswaldo Cruz 2003;98:919\u201325."}, {"Citation": "Lu, LG, Zeng, MD, Mao, YM, Wan, MB, Li, CZ, Chen, CW, et al.. Medicinal Herbs for HCV (oxymatrin). World J Gastroenterol 2003;9:2480\u20133."}, {"Citation": "Wu, J, Zern, MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665\u201372."}, {"Citation": "Ferret, P-J, Hammoud, R, Tulliez, M, Tran, A, Tr\u00e9b\u00e9den, H, Jaffray, P, et al.. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001;33:1173\u201380."}, {"Citation": "Bocci, V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3\u201311."}, {"Citation": "Schwabe, RF, Schnabl, B, Kweon, YO, Brenner, DA. CD40 activates NF-\u03baB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 2001;166:6812\u20139."}, {"Citation": "Dooley, S, Hamzavi, J, Breitkopf, K, Wiercinska, E, Said, HM, Lorenzen, J, et al.. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178\u201391."}, {"Citation": "Marra, F, Efsen, E, Romanelli, RG, Caligiuri, A, Pastacaldi, S, Batignani, G, et al.. Ligands of peroxisome proliferator-activated receptor \u03b3 modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466\u201378."}, {"Citation": "Boya, P, Larrea, E, Sola, I, Majano, P-L, JIMenez, C, Civeira, M-P, et al.. Nuclear factor-\u03bab in the liver of patients with chronic hepatitis c: decreased rela expression is associated with enhanced fibrosis progression. Hepatology 2001;34:1041\u20138."}, {"Citation": "Poynard, T, McHutchison, J, Manns, M, Trepo, C, Lindsay, K, Goodman, Z, et al.. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303\u201313."}, {"Citation": "Mao, Y-M, Zeng, M-D, Lu, L-G, Wan, M-B, Li, C-Z, Chen, C-W, et al.. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol 2004;10:3269."}, {"Citation": "Sookoian, S, Fern\u00e1ndez, MA, Casta\u00f1o, G. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study. World J Gastroenterol 2005;11:7560."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "5"}, {"Year": "2023", "Month": "10", "Day": "30"}, {"Year": "2024", "Month": "3", "Day": "22", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "1", "Day": "8", "Hour": "18", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "8", "Hour": "14", "Minute": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["38190482", "10.1515/jcim-2023-0239", "jcim-2023-0239"]}}], "PubmedBookArticle": []}